Compare BRUN & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRUN | PAHC |
|---|---|---|
| Founded | N/A | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2026 | 2014 |
| Metric | BRUN | PAHC |
|---|---|---|
| Price | $16.62 | $35.83 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $41.25 |
| AVG Volume (30 Days) | ★ 2.4M | 202.0K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | N/A | ★ 2.43 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $3.82 |
| P/E Ratio | ★ N/A | $15.14 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $15.56 | $28.25 |
| 52 Week High | $40.46 | $60.08 |
| Indicator | BRUN | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 51.17 |
| Support Level | $16.34 | $36.31 |
| Resistance Level | $20.91 | $37.92 |
| Average True Range (ATR) | 1.68 | 1.58 |
| MACD | 0.12 | -0.06 |
| Stochastic Oscillator | 14.81 | 28.10 |
Boost Run Inc is an NVIDIA Cloud Provider. Its platform provides GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. Enterprises rely on Boost Run to power their main demanding AI workloads with the performance, security, and reliability their operations require. The group maintains SOC 2 Type II, HIPAA, ISO 27001, and ISO 27701 certifications at the operator level, and partners with data center facilities that uphold equivalent security and compliance standards.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.